pharmadog
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

5,257 catalysts · 4,970 phase readout · 2,357 8k filing · 287 earnings · 276 pdufa · 129 phase 2 completion · 61 phase 1 completion

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-07-27: 28 catalysts2026-07-28: 4 catalysts2026-07-29: 12 catalysts2026-07-30: 12 catalysts2026-07-31: 3 catalysts2026-08-01: 0 catalysts2026-08-02: 0 catalysts2026-08-03: 4 catalysts2026-08-04: 12 catalysts2026-08-05: 14 catalysts2026-08-06: 10 catalysts2026-08-07: 1 catalyst2026-08-08: 0 catalysts2026-08-09: 0 catalysts2026-08-10: 1 catalyst2026-08-11: 1 catalyst2026-08-12: 1 catalyst2026-08-13: 0 catalysts2026-08-14: 0 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 0 catalysts2026-08-18: 1 catalyst2026-08-19: 0 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 0 catalysts2026-08-27: 0 catalysts2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 0 catalysts2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 0 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 0 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 0 catalysts2026-10-14: 0 catalysts2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 0 catalysts2026-10-20: 1 catalyst2026-10-21: 0 catalysts2026-10-22: 1 catalyst2026-10-23: 0 catalysts2026-10-24: 0 catalysts2026-10-25: 0 catalysts
view
agendamonth
show past →
sort
soonestlatesttypesponsoralpha
type: grant×type: phase readout×type: earnings×clear all
type
  • phase readout4,970
  • 8k filing2,357
  • earnings287
  • pdufa276
  • phase 2 completion129
  • phase 1 completion61
phase 1 initiation
32
  • phase 1 2 completion28
  • phase 0 trial completion22
  • phase 2 initiation16
  • therapy area

    no tagged catalysts yet

    Date TBD

    50
    ›RECRUITINGphase readoutNCT02890342: Natural History, Physiology, Microbiome and Biochemistry Studies of Propionic Acidemia

    Sponsor: National Human Genome Research Institute (NHGRI). Phase: . Conditions: Metabolic Disease, Propionic Acidemia, Organic Acidemia

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT06496542: Renal Oxygen Consumption, Insulin Sensitivity, and Daily Caloric Restriction in ADPKD

    Sponsor: University of Colorado, Denver. Phase: NA. Conditions: Autosomal Dominant Polycystic Kidney

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06280742: Study of Neuroinflammation in Multiple Sclerosis by PET-MRI Imaging Using the Radiotracer ([18F]-DPA-714) : a Multicentre Cohort Study (INFLANET)

    Sponsor: Assistance Publique - Hôpitaux de Paris. Phase: NA. Conditions: Multiple Sclerosis

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07535073: Ultrasound-guided Versus Arthroscopic Guided PRF Injection for TMJ Disc Displacement.

    Sponsor: Cairo University. Phase: NA. Conditions: TMJ Disc Displacement With Reduction

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05850273: Mechanism of Action of Interferon in the Treatment of Myeloproliferative Neoplasms

    Sponsor: Institut National de la Santé Et de la Recherche Médicale, France. Phase: . Conditions: Myeloproliferative Neoplasm

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07577973: The Effect of Self-Acupressure on Blood Pressure, Stress, and Well-Being Levels in Individuals With Hypertension

    Sponsor: Abant Izzet Baysal University. Phase: NA. Conditions: PRIMARY HYPERTENSION

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT06024083: Skills Video Intervention for Chinese/Chinese Americans

    Sponsor: Rutgers, The State University of New Jersey. Phase: NA. Conditions: Emotion Regulation, Self Efficacy, Acceptability of Health Care

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT03997383: APOLLO-B: A Study to Evaluate Patisiran in Participants With Transthyretin Amyloidosis With Cardiomyopathy (ATTR Amyloidosis With Cardiomyopathy)

    Sponsor: Alnylam Pharmaceuticals. Phase: PHASE3. Conditions: Transthyretin Amyloidosis (ATTR) With Cardiomyopathy

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07363941: HEIGHT-BASED AND CONVENTIONAL SPINAL ANAESTHETIC DOSING IN GERIATRIC PATIENTS

    Sponsor: Shaheed Mohtarma Benazir Bhutto Institue of Trauma. Phase: NA. Conditions: Geriatric Population, Spinal Anesthesia Induced Hypotension, Spinal Anesthesia in Elderly Patients

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07198841: IBI351 Plus Cetuximab β in Untreated Advanced Non-small Cell Lung Cancer With KRAS G12C Mutation

    Sponsor: Guangdong Association of Clinical Trials. Phase: PHASE2. Conditions: Lung Cancer (Non-Small Cell)

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05807841: Clinical Impact of Intravascular Ultrasound-Based Artificial Intelligence Technologies (INNOVATE-PCI)

    Sponsor: Asan Medical Center. Phase: . Conditions: Coronary Artery Disease

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT05100654: Collaborative Urological Prosthetics Investigation Directive Research Group

    Sponsor: University of Chicago. Phase: EARLY_PHASE1. Conditions: Erectile Dysfunction, Penile Prosthesis Infection

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07477054: A Post-Approval Multicenter Study to Assess the Continued Safety and Effectiveness of the AeroPace® System

    Sponsor: Lungpacer Medical Inc.. Phase: NA. Conditions: Ventilator Induced Diaphragm Dysfunction

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT01711554: Lenalidomide and Dinutuximab With or Without Isotretinoin in Treating Younger Patients With Refractory or Recurrent Neuroblastoma

    Sponsor: National Cancer Institute (NCI). Phase: PHASE1. Conditions: Recurrent Neuroblastoma, Refractory Neuroblastoma

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06269666: P200TxE Diseased Eye Image Collection

    Sponsor: Optos, PLC. Phase: NA. Conditions: Retinal Disease

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06191666: BfedBwell Proof-of-Concept Pilot

    Sponsor: University of Colorado, Denver. Phase: NA. Conditions: Cancer Survivorship, Obesity, Overweight

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07626164: Three Photobiomodulation Wavelengths (635, 940, and 1064 nm) on Chronic Myogenic Temporomandibular Disorder

    Sponsor: Alexandria University. Phase: NA. Conditions: Temporomandibular Disorders

    full page →ctgov ↗
    ›WITHDRAWNphase readoutNCT06103734: A Study to Learn About Zavegepant as a Treatment for Multiple Migraine Attacks in Adult Participants

    Sponsor: Pfizer. Phase: PHASE3. Conditions: Migraine

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT06768034: SecondarY Prevention and maNagement of Myocardial Injury aftER Noncardiac surGerY (SYNERGY) Pilot Trial

    Sponsor: Centre hospitalier de l'Université de Montréal (CHUM). Phase: NA. Conditions: Myocardial Injury After Noncardiac Surgery (MINS)

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06055309: Behavioral Pharmacology of Cannabis in Older Adults

    Sponsor: University of Arkansas. Phase: PHASE1. Conditions: Health Services for the Aged

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05367609: Personalized Perioperative Analgesia Platform (PPAP) for Pediatric Spine Fusion Surgery (sIRB)

    Sponsor: Senthil Sadhasivam. Phase: NA. Conditions: PPAP, Spine Fusion

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT04418999: Safety and Efficacy of Intracanalicular Dexamethasone Compared to Loteprednol Etabonate in Patients With Keratoconus

    Sponsor: Illinois College of Optometry. Phase: EARLY_PHASE1. Conditions: Keratoconus, Dry Eye, Allergy

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07281599: Evaluation of the Q-Pad hrHPV Test System for Identifying Precancer

    Sponsor: Qurasense. Phase: NA. Conditions: HPV Infection, HPV 16 Infection, High Risk HPV, Cervical Cancer Screening, Cervical Cancer Cin Grade, Cervical Cancer (Early Detection), HPV, HPV (Human Papillomavirus)-Associated, HPV DNA, HPV Infections, Screening Test

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT04290663: Systematic Radioiodine Administration Versus Decision of Radioiodine Treatment Guided by a Post-operative Work-up

    Sponsor: Centre Francois Baclesse. Phase: PHASE3. Conditions: Thyroid Cancer, Intermediate Risk

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07627893: Complementary Herbal Approach to Rheumatoid Management Study (CHARMS)

    Sponsor: Singapore General Hospital. Phase: PHASE2. Conditions: Rheumatoid Arthritis (RA)

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06812793: Muscle Endurance in Children With Cystic Fibrosis

    Sponsor: Bezmialem Vakif University. Phase: . Conditions: Cystic Fibrosis

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT05321121: Dexmedotomidine for Acute Pain Control in Patients With Multiple Rib FracturesRandomized Controlled Trial

    Sponsor: University of California, Irvine. Phase: PHASE4. Conditions: Rib Fractures, Pain, Acute

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT05911321: Isa-Pom-Dex in Elderly/Frail Subjects With RRMM

    Sponsor: UNC Lineberger Comprehensive Cancer Center. Phase: PHASE2. Conditions: Multiple Myeloma, Relapse, Refractory, Aging, Co-morbidity

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT05946993: Linking In With Advice and Supports for Men Impacted by Metastatic Cancer

    Sponsor: University College Cork. Phase: NA. Conditions: Survivorship, Prostate Cancer, Kidney Cancer, Urothelial Tract/Bladder Cancer, Nos, Testicular Cancer, Penile Cancer

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT02061306: Celiac Disease Genomic Environmental Microbiome and Metabolomic Study

    Sponsor: Massachusetts General Hospital. Phase: . Conditions: Celiac Disease

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06492304: A Safety and Efficacy Study Evaluating CTX131 in Adult Subjects With Relapsed/Refractory Hematologic Malignancies

    Sponsor: CRISPR Therapeutics. Phase: PHASE1. Conditions: T Cell Lymphoma, B Cell Lymphoma, Acute Myeloid Leukemia

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07471204: Evaluation of Muscle Oxygenation and Recovery Dynamics in Individuals With Knee Osteoarthritis

    Sponsor: Bahçeşehir University. Phase: . Conditions: Osteoarthritis of Knee, Healthy Participants

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT03854552: A Study in Healthy Men Tests How Different Doses of BI 764198 Are Taken up in the Body and How Well They Are Tolerated.

    Sponsor: Boehringer Ingelheim. Phase: PHASE1. Conditions: Healthy

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07410949: Postpartum Acupressure Education and Breastfeeding Outcomes

    Sponsor: Nigde Omer Halisdemir University. Phase: NA. Conditions: Breastfeeding, Lactation, Postpartum Period

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06463158: The Impact of the Family Room App on Caregivers

    Sponsor: University of Nebraska. Phase: NA. Conditions: Well-Being, Psychological, Engagement, Satisfaction, Consumer

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07468955: Impact of Cardiac Rehabilitation on Patient Outcomes

    Sponsor: Kutahya Health Sciences University. Phase: NA. Conditions: Coronary Artery Disease, Coronary Heart Disease

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT00605878: Studies of Skin Microbes in Healthy People and in People With Skin Conditions

    Sponsor: National Human Genome Research Institute (NHGRI). Phase: . Conditions: Eczema, Atopic Dermatitis

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06927115: Comparative Analysis of Mulligan and Maitland Mobilizations Techniques in Adhesive Capsulitis

    Sponsor: Riphah International University. Phase: NA. Conditions: Adhesive Capsulitis of Shoulder

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT04391335: Novel Pulmonary Function Measures for Diagnosis of Bronchiolitis Obliterans Syndrome Following Hematopoietic Stem-Cell Transplantation in Children

    Sponsor: The Hospital for Sick Children. Phase: . Conditions: Bronchiolitis Obliterans Syndrome

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT00083135: N2000-01: Double Infusion of Iodine I 131 Metaiodobenzylguanidine Followed by Autologous Stem Cell Transplantation

    Sponsor: New Approaches to Neuroblastoma Therapy Consortium. Phase: PHASE1. Conditions: Neuroblastoma

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT02710435: REDUCER-I: An Observational Study of the Neovasc Reducer™ System

    Sponsor: Shockwave Medical, Inc.. Phase: . Conditions: Angina Pectoris, Angina Pectoris, Stable, Chronic Stable Angina

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06784908: Stress and Pain in People Living With HIV

    Sponsor: Yale University. Phase: NA. Conditions: HIV, Depression, Cannabis Use Disorder, Stress, Pain

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT07263776: Efficacy and Safety of Interleukin-6 Receptor Inhibitor Combined With Endovascular Treatment in Patients With Acute Anterior Circulation Large Vessel Occlusion Stroke -2

    Sponsor: Capital Medical University. Phase: PHASE3. Conditions: Acute Ischemic Stroke

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07398417: Fibromyalgia Response With Esreboxetine Evaluated Using a Randomized Withdrawal Research Design

    Sponsor: Axsome Therapeutics, Inc.. Phase: PHASE3. Conditions: Fibromyalgia

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT05520840: Evaluation of Peripheral Blood Protein Biomarkers for Colorectal Cancer Screening

    Sponsor: University Hospital, Rouen. Phase: NA. Conditions: Colorectal Cancer

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT05508789: A Study of Donanemab (LY3002813) in Participants With Early Symptomatic Alzheimer's Disease (TRAILBLAZER-ALZ 5)

    Sponsor: Eli Lilly and Company. Phase: PHASE3. Conditions: Alzheimer Disease, Dementia, Brain Diseases, Central Nervous System Diseases, Nervous System Diseases, Tauopathies, Neurodegenerative Diseases, Neurocognitive Disorders, Mental Disorders

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07404293: Zero CDE Technique for Lens Removal During FLACS

    Sponsor: Bochner Eye Institute. Phase: NA. Conditions: Cataract With a Nuclear Sclerosis Grade Between 1 to 3

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07359521: Implementation and Evaluation of a Complex Intervention to Reduce Avoidable Transitions Between Nursing Home and Hospital

    Sponsor: Vrije Universiteit Brussel. Phase: NA. Conditions: Potentially Avoidable Hospitalisations

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT05097521: Assessing Pain, Patient Reported Outcomes and Complementary and Integrative Health

    Sponsor: VA Office of Research and Development. Phase: . Conditions: Chronic Musculoskeletal Pain

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05723614: TRUsted rEsidents and Housing Assistance to Decrease Violence Exposure in New Haven

    Sponsor: Yale University. Phase: NA. Conditions: Firearm Injury

    full page →ctgov ↗
    ← prev
    page 78 of 106
    next →